Amgen Biosimilars Study Predicts Significant Advances

Company Has Invested Over $2bn In Its Portfolio Of 10 Biosimilars

 
• By Akriti Seth
  
Growth
Amgen’s report on biosimilars trends predict significant growth in the US market • Source: Alamy

More from Biosimilars

More from Products